RecruitingNCT04536220

Establish Diagnostic Models Based on Portal Venous Blood for Pancreatic Cancer

Establish a Diagnostic Model Based on Multiple Molecule Profiling and Certain Established Markers for Identification of Pancreatic Cancer

Sponsor

Changhai Hospital

Enrollment

300 participants

Start Date

Jan 1, 2024

Study Type

OBSERVATIONAL

Conditions

Diagnoses Disease

Summary

Explore new markers based on portal venous blood sampling to establish novel diagnostic models for identification of malignant pancreatic mass.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting blood samples from the portal vein (the large vein that drains the pancreas) to develop better blood-based tests for detecting and diagnosing pancreatic cancer. **You may be eligible if...** - You are between 18 and 75 years old - You have been found to have a solid mass in the pancreas on imaging (ultrasound, CT, or MRI) that is at least 1 cm - You are undergoing an endoscopic ultrasound procedure - You can provide written consent **You may NOT be eligible if...** - You are pregnant - You have a cystic (fluid-filled) pancreatic lesion rather than a solid mass - You are on blood thinners that cannot be temporarily stopped - You have a blood clotting disorder - You have severe heart or lung problems that make sedation unsafe - You have a history of mental illness Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.